They will easily have enough to complete the DME trial and probably have over $20m still in the bank.
It would be reasonable to assume that the CEO is not sitting on her hands, but will be planning the strategy for the phase 3 trial for WMD, with or without a major partner.
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea Receives A$14.6m R&D Tax Incentive
Ann: Opthea Receives A$14.6m R&D Tax Incentive, page-6
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
49.0¢ |
Change
0.040(8.89%) |
Mkt cap ! $603.2M |
Open | High | Low | Value | Volume |
46.0¢ | 49.0¢ | 45.5¢ | $3.430M | 7.316M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7000 | 48.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.0¢ | 156010 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7000 | 0.480 |
1 | 24010 | 0.475 |
1 | 24010 | 0.470 |
1 | 24010 | 0.465 |
3 | 46810 | 0.460 |
Price($) | Vol. | No. |
---|---|---|
0.490 | 156010 | 6 |
0.495 | 524010 | 2 |
0.500 | 24010 | 1 |
0.505 | 24010 | 1 |
0.520 | 13000 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |